Literature DB >> 23692396

Long-term results of intratympanic prednisolone injection in patients with idiopathic sudden sensorineural hearing loss.

Roberto Filipo1, Giuseppe Attanasio, Laura Cagnoni, Eleonora Masci, Francesca Y Russo, Giulia Cartocci, Alessia Di Mario, Edoardo Covelli.   

Abstract

CONCLUSION: The results demonstrate the stability of the efficacy over time of the intratympanic prednisolone protocol and they suggest that the spontaneous recovery does not significantly influence the long-term evaluation of intratympanic therapy. A 10-day follow-up after 3 days of intratympanic prednisolone administration can be considered a sufficient period to evaluate the effectiveness of the undertaken therapy.
OBJECTIVE: To assess the stability of the efficacy over time of intratympanic steroid therapy for patients with idiopathic sudden sensorineural hearing loss.
METHODS: A total of 122 patients received an intratympanic steroid injection of prednisolone daily for 3 days. Audiograms were performed before therapy and at 10 days and 1 year after therapy. Successful recovery was defined as complete and partial recovery using Siegel's criteria and complete and marked recovery following Furuhashi's criteria.
RESULTS: The comparison of audiometric data at study entry, at 10 days, and at 1 year after the treatment showed a statistically significant improvement of the mean pure tone audiometry. The evaluation of the hearing outcomes demonstrated a statistically significant improvement, with similar success rates when evaluated 10 days and 1 year after the treatment. Comparing the hearing outcomes at 1 year with the results at 10 days, no significant difference was detected between these two time points.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23692396     DOI: 10.3109/00016489.2013.788791

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Idiopathic sudden sensorineural hearing loss in Japan.

Authors:  Tsutomu Nakashima; Hiroaki Sato; Kiyofumi Gyo; Naohito Hato; Tadao Yoshida; Mariko Shimono; Masaaki Teranishi; Michihiko Sone; Yukari Fukunaga; Gen Kobashi; Kunihiko Takahashi; Shigeyuki Matsui; Kaoru Ogawa
Journal:  Acta Otolaryngol       Date:  2014-11       Impact factor: 1.494

2.  Concurrent hyperbaric oxygen therapy and intratympanic steroid application as salvage therapy after severe sudden sensorineural hearing loss.

Authors:  Hans Lamm; Claus Müller-Kortkamp; Athanasia Warnecke; Friederike Pohl; Gerrit Paasche; Thomas Lenarz; Stefan R O Stolle
Journal:  Clin Case Rep       Date:  2016-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.